Long-term follow-up of photodynamic therapy for mycosis fungoides

Acta Dermato-Venereologica

Volumn 88, Issue 3, 2008, Pages 288-290

  Edström, Desiree Wiegleb ^a   Hedblad, Mari Anne ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LETTER; MALE; MYCOSIS FUNGOIDES; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 44349183867     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0409     Document Type: Letter

References (16)

1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.
2. Weinstock MA. Epidemiology of mycosis fungoides. Sem Dermatol 1994; 13: 154-159.
3. Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and UK Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149: 1095-1107.
4. Zackheim HS, Amin S, Kashani-Sabet M, McMillan A. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol 1999; 40: 418-425.
5. Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome. Arch Dermatol 2003; 139: 857-866.
6. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-aminolevulinic acid sensitisation and laser irradiation. Br J Dermatol 1994; 130: 743-751.
7. Wolf P, Fink-Puches R, Cerroni L, Kerl H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 1994; 31: 678-680.
8. Amman, R. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 1995; 32: 541.
9. Eich D, Eich HT, Otte TH, Ghilescu H-G, Stadler R. Photodynamishce Therapie kuntaner T-Zell-Lymphome in besonderer Lokalisation. Hautarzt 1999; 50: 109-114.
10. Oreinstein A, Haik J, Tamir J, Winkler E, Trau H, Malik Z, et al. Dermatol Surg 2000; 26: 765-769.
11. Markham T. Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides. Br J Dermatol 2001; 144: 1262-1295.
12. Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol 2002; 27: 516-518.
13. Edstrom DW, Porwit A, Ros A-M. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. Acta Derm Venereol 2001; 81: 184-188.
14. Coors EA, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol 2004; 50: 363-367.
15. Zane C, Venturini M, Sala R, Calzavara-Pinto P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cll lymphoma. Photodermatol Photoimmunol Photomed 2006; 22: 254-258.
16. Grapengiesser S, Gudmundsson F, Larkö O, Ericson M, Rosén, Wennberg A-M. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-497.